Cline provides an update on current StemCART exvivo testing project
Cline Scientific AB (“Cline” or “The Company”) has conducted 18 more implantation experiments on cartilage specimens in the lab. This, in addition to the 12 experiments carried out in the first stage showing matrix functionality, was communicated early in April 2022.The primary focus of the current tests has been on verifying that the iPS cells have undergone the differentiation towards the target cell and quality in a quantifiable manner. These include quantifying specific markers through qPCR and analyzing cell number and cell viability. This work will form the basis of Quality Assurance (